Products

SLENDACOR® Weight Management Complex is a three gold-standard clinical trials designed to build trust with consumers, non-stimulant thermogenesis, helps burn up to 15% more calories at rest etc.

AprèsFlex® 5-Day Joint Support is a proprietary, botanical ingredient that can help your customers improve mobility, rapidly and then over an extended period of time. AprèsFlex helps people manage inflammation that comes from aging, intense physical activity, and sports – so you can offer it to a broad customer base. Around the world, people have turned to AprèsFlex more than a billion times as a drug-free approach to joint comfort and enhanced mobility.

AquaLOX is a water-soluble version of PLT’s Boswellia Serrata extract 5-LOXIN®. 5-LOXIN has been clinically demonstrated to improve joint comfort and protect against cartilage degradation. In addition to being water-soluble, AquaLOX represents a major breakthrough with its pleasant taste profile, allowing – for the first time – the opportunity to feature PLT’s leading joint health solutions in taste-sensitive formulations such as chewables, gummies, stick-packs, shots and more.

AlvioLife® is a proprietary composition of extracts of Boswellia serrata gum resin [standardized to 30% 3-O-acetyl-11-keto-ß-boswellic acid (AKBA)] and Aegle marmelos dried fruit – designed to support a healthy respiratory system. It works to help maintain clear airways and reduce the impact of environmental irritants. What does that mean for you? An exciting ingredient for respiratory health and a perfect complement in immune health formulations.

5-LOXIN® is a patented, clinically-studied dietary supplement ingredient. In human studies, 5-LOXIN was shown to support joint health and function and protect against collagen degradation. 5-LOXIN® inhibits an enzyme called 5-lipoxygenase. 5-LOX inhibitors follow a distinctly different path way than COX-2 inhibitors, and while both are involved in the breakdown of arachidonic acid, 5-LOX inhibitors do not exhibit the potentially negative effects that have been associated with COX-2 inhibitors and non-redox 5-LOX inhibitor, which means that its action is very targeted, not affecting other systems with COX-2 inhibitors.